Neither the presence of established worrisome features nor GNAS or KRAS mutations appear effective in identifying high‐grade dysplasia among IPMN patients, which is the only true indication for surgery. Here, GNAS is linked to pancreatic intraductal papillary-mucinous neoplasm.